78 related articles for article (PubMed ID: 9011069)
1. Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease.
Hermsen C; van de Wiel T; Mommers E; Sauerwein R; Eling W
Parasitology; 1997 Jan; 114 ( Pt 1)():7-12. PubMed ID: 9011069
[TBL] [Abstract][Full Text] [Related]
2. Gamma delta T-cell function in pathogenesis of cerebral malaria in mice infected with Plasmodium berghei ANKA.
Yañez DM; Batchelder J; van der Heyde HC; Manning DD; Weidanz WP
Infect Immun; 1999 Jan; 67(1):446-8. PubMed ID: 9864254
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice.
Lv Y; Wu S; Nie Q; Liu S; Xu W; Chen G; Du Y; Chen J
Int Immunopharmacol; 2024 May; 132():111982. PubMed ID: 38569430
[TBL] [Abstract][Full Text] [Related]
4. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8
Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN
Front Immunol; 2019; 10():248. PubMed ID: 30846985
[TBL] [Abstract][Full Text] [Related]
5. Glucose metabolism mediates disease tolerance in cerebral malaria.
Wang A; Huen SC; Luan HH; Baker K; Rinder H; Booth CJ; Medzhitov R
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11042-11047. PubMed ID: 30291189
[TBL] [Abstract][Full Text] [Related]
6. Deletion of T cells bearing the V beta8.1 T-cell receptor following mouse mammary tumor virus 7 integration confers resistance to murine cerebral malaria.
Gorgette O; Existe A; Boubou MI; Bagot S; Guénet JL; Mazier D; Cazenave PA; Pied S
Infect Immun; 2002 Jul; 70(7):3701-6. PubMed ID: 12065512
[TBL] [Abstract][Full Text] [Related]
7. Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria.
Fain CE; Zheng J; Jin F; Ayasoufi K; Wu Y; Lilley MT; Dropik AR; Wolf DM; Rodriguez RC; Aibaidula A; Tritz ZP; Bouchal SM; Pewe LL; Urban SL; Chen Y; Chang SY; Hansen MJ; Kachergus JM; Shi J; Thompson EA; Jensen HE; Harty JT; Parney IF; Sun J; Wu LJ; Johnson AJ
Brain; 2024 Feb; 147(2):566-589. PubMed ID: 37776513
[TBL] [Abstract][Full Text] [Related]
8. Lung endothelial cell antigen cross-presentation to CD8
Claser C; Nguee SYT; Balachander A; Wu Howland S; Becht E; Gunasegaran B; Hartimath SV; Lee AWQ; Theng Theng Ho J; Bing Ong C; Newell EW; Goggi J; Guan Ng L; Renia L
Nat Commun; 2019 Sep; 10(1):4241. PubMed ID: 31534124
[TBL] [Abstract][Full Text] [Related]
9. Acute lung injury is prevented by monocyte locomotion inhibitory factor in an experimental severe malaria mouse model.
Jackeline Pérez-Vega M; Manuel Corral-Ruiz G; Galán-Salinas A; Silva-García R; Mancilla-Herrera I; Barrios-Payán J; Fabila-Castillo L; Hernández-Pando R; Enid Sánchez-Torres L
Immunobiology; 2024 Jul; 229(4):152823. PubMed ID: 38861873
[TBL] [Abstract][Full Text] [Related]
10. Liver-stage Plasmodium infection tunes clinical outcomes.
Kaushansky A; Minkah N
Trends Parasitol; 2023 May; 39(5):321-322. PubMed ID: 36935339
[TBL] [Abstract][Full Text] [Related]
11. Pathogenetic mechanisms and treatment targets in cerebral malaria.
Hadjilaou A; Brandi J; Riehn M; Friese MA; Jacobs T
Nat Rev Neurol; 2023 Nov; 19(11):688-709. PubMed ID: 37857843
[TBL] [Abstract][Full Text] [Related]
12. Identification of disease-related genes in Plasmodium berghei by network module analysis.
Lin J; Zeng S; Chen Q; Liu G; Pan S; Liu X
BMC Microbiol; 2023 Sep; 23(1):264. PubMed ID: 37735351
[TBL] [Abstract][Full Text] [Related]
13. Live Vaccination with Blood-Stage
Imai T; Ngo-Thanh H; Suzue K; Shimo A; Nakamura A; Horiuchi Y; Hisaeda H; Murakami T
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632518
[TBL] [Abstract][Full Text] [Related]
14. Eosinophils Suppress the Migration of T Cells Into the Brain of
Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B
Front Immunol; 2021; 12():711876. PubMed ID: 34659202
[TBL] [Abstract][Full Text] [Related]
15. Attenuated T Cell Responses Are Associated With the Blockade of Cerebral Malaria Development by YOP1-Deficient
Hai L; Shi X; Wang Q
Front Immunol; 2021; 12():642585. PubMed ID: 34025654
[TBL] [Abstract][Full Text] [Related]
16. The C-type Lectin Receptor CLEC12A Recognizes Plasmodial Hemozoin and Contributes to Cerebral Malaria Development.
Raulf MK; Johannssen T; Matthiesen S; Neumann K; Hachenberg S; Mayer-Lambertz S; Steinbeis F; Hegermann J; Seeberger PH; Baumgärtner W; Strube C; Ruland J; Lepenies B
Cell Rep; 2019 Jul; 28(1):30-38.e5. PubMed ID: 31269448
[TBL] [Abstract][Full Text] [Related]
17. KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria.
Hortle E; Starrs L; Brown FC; Jane SM; Curtis DJ; McMorran BJ; Foote SJ; Burgio G
Sci Rep; 2019 Apr; 9(1):6356. PubMed ID: 31015511
[TBL] [Abstract][Full Text] [Related]
18. MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.
Riggle BA; Sinharay S; Schreiber-Stainthorp W; Munasinghe JP; Maric D; Prchalova E; Slusher BS; Powell JD; Miller LH; Pierce SK; Hammoud DA
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12024-E12033. PubMed ID: 30514812
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Malaria in Mouse and Man.
Ghazanfari N; Mueller SN; Heath WR
Front Immunol; 2018; 9():2016. PubMed ID: 30250468
[TBL] [Abstract][Full Text] [Related]
20. Inducible Costimulator Expressing T Cells Promote Parasitic Growth During Blood Stage
Jogdand GM; Sengupta S; Bhattacharya G; Singh SK; Barik PK; Devadas S
Front Immunol; 2018; 9():1041. PubMed ID: 29892278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
